226 related articles for article (PubMed ID: 34946547)
41. A Phase II, Multicenter, Single-Arm Study of Mipsagargin (G-202) as a Second-Line Therapy Following Sorafenib for Adult Patients with Progressive Advanced Hepatocellular Carcinoma.
Mahalingam D; Peguero J; Cen P; Arora SP; Sarantopoulos J; Rowe J; Allgood V; Tubb B; Campos L
Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31212948
[No Abstract] [Full Text] [Related]
42. Activation of oxazaphosphorines by cytochrome P450: application to gene-directed enzyme prodrug therapy for cancer.
Roy P; Waxman DJ
Toxicol In Vitro; 2006 Mar; 20(2):176-86. PubMed ID: 16293390
[TBL] [Abstract][Full Text] [Related]
43. Somatostatin receptor-mediated specific delivery of paclitaxel prodrugs for efficient cancer therapy.
Huo M; Zhu Q; Wu Q; Yin T; Wang L; Yin L; Zhou J
J Pharm Sci; 2015 Jun; 104(6):2018-2028. PubMed ID: 25820241
[TBL] [Abstract][Full Text] [Related]
44. Development of a novel prodrug of paclitaxel that is cleaved by prostate-specific antigen: an in vitro and in vivo evaluation study.
Elsadek B; Graeser R; Esser N; Schäfer-Obodozie C; Abu Ajaj K; Unger C; Warnecke A; Saleem T; El-Melegy N; Madkor H; Kratz F
Eur J Cancer; 2010 Dec; 46(18):3434-44. PubMed ID: 20933385
[TBL] [Abstract][Full Text] [Related]
45. Effects of the sesquiterpene lactone tetraesters thapsigargicin and thapsigargin, from roots of Thapsia garganica L., on isolated spinach chloroplasts.
Santarius KA; Falsone G; Haddad H
Toxicon; 1987; 25(4):389-99. PubMed ID: 3617076
[TBL] [Abstract][Full Text] [Related]
46. Presence of a thapsigargin-sensitive calcium pump in Trypanosoma evansi: Immunological, physiological, molecular and structural evidences.
Pérez-Gordones MC; Serrano ML; Rojas H; Martínez JC; Uzcanga G; Mendoza M
Exp Parasitol; 2015 Dec; 159():107-17. PubMed ID: 26297682
[TBL] [Abstract][Full Text] [Related]
47. Structure/activity relationship of thapsigargin inhibition on the purified Golgi/secretory pathway Ca
Chen J; De Raeymaecker J; Hovgaard JB; Smaardijk S; Vandecaetsbeek I; Wuytack F; Møller JV; Eggermont J; De Maeyer M; Christensen SB; Vangheluwe P
J Biol Chem; 2017 Apr; 292(17):6938-6951. PubMed ID: 28264934
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of the ER Ca2+ pump forces multidrug-resistant cells deficient in Bak and Bax into necrosis.
Janssen K; Horn S; Niemann MT; Daniel PT; Schulze-Osthoff K; Fischer U
J Cell Sci; 2009 Dec; 122(Pt 24):4481-91. PubMed ID: 19920074
[TBL] [Abstract][Full Text] [Related]
49. Effects of various amino acid 256 mutations on sarcoplasmic/endoplasmic reticulum Ca2+ ATPase function and their role in the cellular adaptive response to thapsigargin.
Yu M; Lin J; Khadeer M; Yeh Y; Inesi G; Hussain A
Arch Biochem Biophys; 1999 Feb; 362(2):225-32. PubMed ID: 9989931
[TBL] [Abstract][Full Text] [Related]
50. Thapsigargin resistance in human prostate cancer cells.
O'Neill JP; Velalar CN; Lee DI; Zhang B; Nakanishi T; Tang Y; Selaru F; Ross D; Meltzer SJ; Hussain A
Cancer; 2006 Aug; 107(3):649-59. PubMed ID: 16770788
[TBL] [Abstract][Full Text] [Related]
51. C-Jun N-terminal kinase is required for phorbol ester- and thapsigargin-induced apoptosis in the androgen responsive prostate cancer cell line LNCaP.
Engedal N; Korkmaz CG; Saatcioglu F
Oncogene; 2002 Feb; 21(7):1017-27. PubMed ID: 11850819
[TBL] [Abstract][Full Text] [Related]
52. Current prodrug design for drug discovery.
Hsieh PW; Hung CF; Fang JY
Curr Pharm Des; 2009; 15(19):2236-50. PubMed ID: 19601825
[TBL] [Abstract][Full Text] [Related]
53. Baculovirus p35 and Z-VAD-fmk inhibit thapsigargin-induced apoptosis of breast cancer cells.
Qi XM; He H; Zhong H; Distelhorst CW
Oncogene; 1997 Sep; 15(10):1207-12. PubMed ID: 9294614
[TBL] [Abstract][Full Text] [Related]
54. Serine hydrolase inhibitors block necrotic cell death by preventing calcium overload of the mitochondria and permeability transition pore formation.
Yun B; Lee H; Ghosh M; Cravatt BF; Hsu KL; Bonventre JV; Ewing H; Gelb MH; Leslie CC
J Biol Chem; 2014 Jan; 289(3):1491-504. PubMed ID: 24297180
[TBL] [Abstract][Full Text] [Related]
55. Apoptosis induction by the glucocorticoid hormone dexamethasone and the calcium-ATPase inhibitor thapsigargin involves Bc1-2 regulated caspase activation.
McColl KS; He H; Zhong H; Whitacre CM; Berger NA; Distelhorst CW
Mol Cell Endocrinol; 1998 Apr; 139(1-2):229-38. PubMed ID: 9705090
[TBL] [Abstract][Full Text] [Related]
56. Prodrug applications for targeted cancer therapy.
Giang I; Boland EL; Poon GM
AAPS J; 2014 Sep; 16(5):899-913. PubMed ID: 25004822
[TBL] [Abstract][Full Text] [Related]
57. Increasing oral absorption of polar neuraminidase inhibitors: a prodrug transporter approach applied to oseltamivir analogue.
Gupta D; Varghese Gupta S; Dahan A; Tsume Y; Hilfinger J; Lee KD; Amidon GL
Mol Pharm; 2013 Feb; 10(2):512-22. PubMed ID: 23244438
[TBL] [Abstract][Full Text] [Related]
58. Effect of Bax deficiency on death receptor 5 and mitochondrial pathways during endoplasmic reticulum calcium pool depletion-induced apoptosis.
He Q; Montalbano J; Corcoran C; Jin W; Huang Y; Sheikh MS
Oncogene; 2003 May; 22(17):2674-9. PubMed ID: 12730681
[TBL] [Abstract][Full Text] [Related]
59. Oral delivery of anticancer drugs II: the prodrug strategy.
Mazzaferro S; Bouchemal K; Ponchel G
Drug Discov Today; 2013 Jan; 18(1-2):93-8. PubMed ID: 22960308
[TBL] [Abstract][Full Text] [Related]
60. Mechanisms of resistance and adaptation to thapsigargin in androgen-independent prostate cancer PC3 and DU145 cells.
Lee DI; Sumbilla C; Lee M; Natesavelalar C; Klein MG; Ross DD; Inesi G; Hussain A
Arch Biochem Biophys; 2007 Aug; 464(1):19-27. PubMed ID: 17475205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
